Commonwealth Equity Services, Inc - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 44 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Commonwealth Equity Services, Inc ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2016$4,000
-75.0%
44,720
+2.8%
0.00%
Q2 2016$16,000
-5.9%
43,5000.0%0.00%
Q1 2016$17,0000.0%43,500
+2.4%
0.00%
Q4 2015$17,000
-29.2%
42,5000.0%0.00%
Q3 2015$24,000
-46.7%
42,500
-48.5%
0.00%
Q2 2015$45,000
-31.8%
82,500
+2.5%
0.00%
-100.0%
Q1 2015$66,000
+3.1%
80,5000.0%0.00%0.0%
Q4 2014$64,000
-22.9%
80,500
-1.2%
0.00%0.0%
Q3 2014$83,000
+18.6%
81,5000.0%0.00%0.0%
Q2 2014$70,00081,5000.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q1 2016
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,200,000$858,0000.10%
SABBY MANAGEMENT, LLC 1,856,019$724,0000.04%
HOME FEDERAL BANK OF TENNESSEE 100,000$39,0000.03%
Cutter & CO Brokerage, Inc. 94,500$37,0000.02%
WADE G W & INC 80,000$31,0000.01%
Marcus Capital, LLC 15,000$6,0000.01%
PRINCETON CAPITAL MANAGEMENT LLC 10,000$4,0000.01%
B. Riley Wealth Advisors, Inc. 28,000$11,0000.00%
Estate Counselors, LLC 10,000$4,0000.00%
Focused Wealth Management, Inc 2,955$1,0000.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders